Prevalence of genetic testing according to hemophilia type, severity, and priority group
| . | Genetic testing performed . | Genetic testing not yet performed . | Total, n (100%) . | P value . |
|---|---|---|---|---|
| HA | .213 | |||
| Severity in family | ||||
| Severe | 129 (39.3%) | 199 (60.7%) | 328 | |
| Moderate | 19 (28.8%) | 47 (71.2%) | 66 | |
| Mild | 93 (35.0%) | 173 (65.0%) | 266 | |
| HB | .001 | |||
| Severity in family | ||||
| Severe | 31 (32.6%) | 64 (67.4%) | 95 | |
| Moderate | 38 (59.4%) | 26 (40.6%) | 64 | |
| Mild | 25 (30.9%) | 56 (69.1%) | 81 | |
| HA | <.001 | |||
| Priority group 1 | 167 (43.0%) | 221 (57.0%) | 388 | |
| Priority group 2 | 43 (26.4%) | 120 (73.6%) | 163 | |
| Priority group 3 | 25 (30.9%) | 56 (69.1%) | 81 | |
| Priority group 4 | 1 (5.3%) | 18 (94.7%) | 19 | |
| HB | .009 | |||
| Priority group 1 | 69 (44.5%) | 86 (55.5%) | 155 | |
| Priority group 2 | 13 (21.7%) | 47 (78.3%) | 60 | |
| Priority group 3 | 11 (45.8%) | 13 (54.2%) | 24 | |
| Priority group 4 | 1 (100.0%) | 0 (0.0%) | 1 |
| . | Genetic testing performed . | Genetic testing not yet performed . | Total, n (100%) . | P value . |
|---|---|---|---|---|
| HA | .213 | |||
| Severity in family | ||||
| Severe | 129 (39.3%) | 199 (60.7%) | 328 | |
| Moderate | 19 (28.8%) | 47 (71.2%) | 66 | |
| Mild | 93 (35.0%) | 173 (65.0%) | 266 | |
| HB | .001 | |||
| Severity in family | ||||
| Severe | 31 (32.6%) | 64 (67.4%) | 95 | |
| Moderate | 38 (59.4%) | 26 (40.6%) | 64 | |
| Mild | 25 (30.9%) | 56 (69.1%) | 81 | |
| HA | <.001 | |||
| Priority group 1 | 167 (43.0%) | 221 (57.0%) | 388 | |
| Priority group 2 | 43 (26.4%) | 120 (73.6%) | 163 | |
| Priority group 3 | 25 (30.9%) | 56 (69.1%) | 81 | |
| Priority group 4 | 1 (5.3%) | 18 (94.7%) | 19 | |
| HB | .009 | |||
| Priority group 1 | 69 (44.5%) | 86 (55.5%) | 155 | |
| Priority group 2 | 13 (21.7%) | 47 (78.3%) | 60 | |
| Priority group 3 | 11 (45.8%) | 13 (54.2%) | 24 | |
| Priority group 4 | 1 (100.0%) | 0 (0.0%) | 1 |